Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “tacrolimus”

4 pharma patents match "tacrolimus" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 4
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 4 pharmaceutical patents matching "tacrolimus" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

4 results for “tacrolimus” · 30,257 patents in full index Clear search

  1. US 20260108463

    NANOEMULSION FORMULATION WITH IMPROVED TACROLIMUS STABILITY AND SKIN PENETRATION

    BIOFRONTERA BIOSCIENCE GMBH [DE] · Granted Apr 23, 2026 · Expires Apr 18, 2046

    granted
  2. US 11291657

    Methods of treating inflammatory bowel disease with AMD3100 and Tacrolimus

    MedRegen, LLC · Granted Apr 5, 2022 · Expires Mar 31, 2042

    granted
  3. US 10420751

    Methods of treating inflammatory bowel disease with AMD3100 and tacrolimus

    MedRegen, LLC · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  4. US 6187745

    Method of preventing nephrotoxicity caused by cyclosporins and tacrolimus

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 13, 2001 · Expires Feb 8, 2021

    expired